PAVMED INC (PAVM)

US70387R4039 - Common Stock

2.27  +0.08 (+3.65%)

Fundamental Rating

1

PAVM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 193 industry peers in the Health Care Equipment & Supplies industry. PAVM has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, PAVM is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

PAVM had negative earnings in the past year.
In the past year PAVM has reported a negative cash flow from operations.
In the past 5 years PAVM always reported negative net income.
PAVM had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of PAVM (-200.11%) is worse than 93.75% of its industry peers.
Industry RankSector Rank
ROA -200.11%
ROE N/A
ROIC N/A
ROA(3y)-141.22%
ROA(5y)-165.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PAVM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PAVM has been reduced compared to 1 year ago.
The number of shares outstanding for PAVM has been reduced compared to 5 years ago.
PAVM has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -20.16, we must say that PAVM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -20.16, PAVM is doing worse than 88.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -20.16
ROIC/WACCN/A
WACC8.12%

2.3 Liquidity

A Current Ratio of 0.45 indicates that PAVM may have some problems paying its short term obligations.
PAVM has a Current ratio of 0.45. This is amonst the worse of the industry: PAVM underperforms 96.35% of its industry peers.
PAVM has a Quick Ratio of 0.45. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.45, PAVM is doing worse than 95.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45

More info and screens

4

3. Growth

3.1 Past

PAVM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -116.55%.
Looking at the last year, PAVM shows a very strong growth in Revenue. The Revenue has grown by 547.11%.
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q47.54%
Revenue 1Y (TTM)547.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q853.64%

3.2 Future

PAVM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.60% yearly.
The Revenue is expected to grow by 149.88% on average over the next years. This is a very strong growth
EPS Next Y34.9%
EPS Next 2Y24.92%
EPS Next 3Y24.6%
EPS Next 5YN/A
Revenue Next Year141.79%
Revenue Next 2Y167.55%
Revenue Next 3Y245.04%
Revenue Next 5Y149.88%

3.3 Evolution

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PAVM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PAVM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PAVM's earnings are expected to grow with 24.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.92%
EPS Next 3Y24.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PAVM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PAVMED INC

NASDAQ:PAVM (5/7/2024, 11:28:23 AM)

2.27

+0.08 (+3.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.41M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -200.11%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y34.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)547.11%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y